Abstract
It is a known fact that inflammation affects several physiological processes, including the functioning of the central nervous system. Additionally, impairment of lipid mechanisms/pathways have been associated with a number of neurodegenerative disorders and Alzheimer's Disease (AD) is one of them. However, much attention has been given to the link between tau and beta- amyloid hypothesis in AD pathogenesis/prognosis. Increasing evidences suggest that biologically active lipid molecules could influence the pathophysiology of AD via a different mechanism of inflammation. This review intends to highlight the role of inflammatory responses in the context of AD with the emphasis on biochemical pathways of lipid metabolism enzyme, 5-lipoxygenase (5- LO).
Cite
CITATION STYLE
Siddiqui, A., Akhtar, S., Shah, Z., Othman, I., & Kumari, Y. (2020). Inflammation Drives Alzheimer’s Disease: Emphasis on 5-lipoxygenase Pathways. Current Neuropharmacology, 19(6), 885–895. https://doi.org/10.2174/1570159x18666200924122732
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.